Overview

Internal Radiation Therapy in Treating Patients With Liver Metastases From Neuroendocrine Tumors

Status:
Terminated
Trial end date:
2007-10-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. PURPOSE: This phase II trial is studying how well internal radiation therapy works in treating patients with liver metastases from neuroendocrine tumors.
Phase:
Phase 2
Details
Lead Sponsor:
Vanderbilt-Ingram Cancer Center
Collaborator:
National Cancer Institute (NCI)
Treatments:
Octreotide